Skip to content

Determination of Glycaemic Index and Insulinaemic Index Values of 6 Food Products in 3 Separate Research Centers

Determination of Glycaemic Index and Insulinaemic Index Values of 6 Cereal Products in 3 Separate Research Centers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01870570
Enrollment
48
Registered
2013-06-06
Start date
2013-06-30
Completion date
2013-12-31
Last updated
2014-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glycaemia, Insulinemia

Keywords

Glycaemia, Insulinemia

Brief summary

The purpose of this study is to determine and compare the glycaemic index values and response parameters of 6 food products between 3 laboratories.

Detailed description

This study will be performed at 3 centers and 15 subjects will be recruited at each center.

Interventions

OTHERFood Product A: Corn Flakes
OTHERFood Product B: Ginger Bread
OTHERFood Product C:Sandwiched Breakfast Biscuit
OTHERFood Product D: Crackers Nature
OTHERFood Product E: Breakfast Biscuit
OTHERFood Product F: White Bread

Sponsors

BioFortis
CollaboratorOTHER
Glycemic Index Laboratories, Inc
CollaboratorINDUSTRY
University of Sydney
CollaboratorOTHER
Mondelēz International, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

1. Aged 18-35 years inclusive. 2. Non-smoker. 3. BMI 19.0-25.0 kg/m2 inclusive. 4. Healthy subjects with: * Fasting plasma glucose \< 5,6 mM (ADA criteria,2011) * Insulin resistance index based on homeostasis model assessment (HOMA-IR) \<1.70 * Fasting lipids: triglyceride \<1.70mmol/L, LDL-cholesterol\<5.00 mmol/L and HDL-cholesterol \>1.03mmol/L for males or \>1.29mmol/L for females (IDF criteria for metabolic syndrome, 2006) * Gamma-GT, AST and ALT \<1.5 times the upper limit of normal (ULN) * Complete blood count: Normal full blood count according to the investigator * Systolic blood pressure \<130 mmHg * Diastolic blood pressure \<85 mmHg * Resting heart rate 50-90 beats per minutes (after 3 minutes rest). 5. Stable dietary habits; normal eating patterns; no history of eating disorders or strict dieting. 6. Moderate level of physical activity (from basic daily activity to a high level of physical activity (regular physical activity at least 3 times per week)) 7. Able to fast for at least 10 hours the night before each test session. 8. Able to refrain from eating legumes and drinking alcohol the day before each test session. 9. Subject covered by social security or covered by a similar system 10. Subject not taking any treatment for anorexia, weight loss, or any form of treatment likely to interfere with metabolism or dietary habits 11. Subject having given written consent to take part in the study

Exclusion criteria

1. Following a restrictive or specific diet. 2. Suffering from any inflammatory or metabolic diseases 3. Suffering from mental illness. 4. Suffering from any food allergies or hypersensitivities (wheat, milk, egg, nuts, etc). 5. Taking any regular prescription medication at the time of inclusion that should interfere with carbohydrate metabolism (except regular oral contraception medication, thyroid replacement therapy) 6. Female who is pregnant (positive test results), lactating, planning pregnancy or not using acceptable contraceptive. 7. Subject having taken part in another clinical trial within the last week. 8. Subject currently taking part in another clinical trial or being in the exclusion period of another clinical trial. 9. Subject undergoing general anaesthesia in the month prior to inclusion. 10. Subject in a situation which in the investigator's opinion could interfere with optimal participation in the present study or could constitute a special risk for the subject.

Design outcomes

Primary

MeasureTime frame
Determine and Perform Inter-Laboratory Comparison of Glycaemic Index Values of 6 Food Products0-120 minutes

Secondary

MeasureTime frame
Determine and Perform Inter-Laboratory Comparison of the Glucose Cmax for Each of the 6 Food Products0-120 minutes
Determine and Perform Inter-Laboratory Comparison of the Blood Glucose Delta Peak for Each of the 6 Food Products0-120 minutes
Determine and Perform Inter-Laboratory Comparison of Insulinemic Index for Each of the 6 Food Products0-120 minutes
Determine and Perform Inter-Laboratory Comparison of the Incremental Area Under the Curve (iAUC) of Insulinemia for Each of the 6 Food Products01-20 minutes
Determine and Perform Inter-Laboratory Comparison of Incremental Area Under the Curve (iAUC) of Glycaemia for Each of the 6 Food Products0-120 minutes
Determine and Perform Inter-Laboratory Comparison of the Blood Insulin Delta Peak for Each of the 6 Food Products0-120 minutes
Determine the Intra-Laboratory Variability for the iAUC of Glycaemia0-120 minutes
Determine the Intra-Laboratory Variability of the iAUC of Insulinemia0-120 minutes
Determination and Perform Inter-Laboratory Comparison of Insulin Cmax for Each of the 6 Food Products0-120 minutes

Countries

Australia, Canada, France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026